{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:21:31Z","timestamp":1779916891917,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["No. 2022-PUMCH-B-005"],"award-info":[{"award-number":["No. 2022-PUMCH-B-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-04935-5","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:44:39Z","timestamp":1751071479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and survival outcomes of rectal cancer patients across different mrT3 substages determined by rectal MRI"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-1100","authenticated-orcid":false,"given":"Ganbin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-9344","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-9068","authenticated-orcid":false,"given":"Xiaoyuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-1733","authenticated-orcid":false,"given":"Lai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-621X","authenticated-orcid":false,"given":"Junyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-6987","authenticated-orcid":false,"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-1227","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-3028","authenticated-orcid":false,"given":"Guole","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"1","key":"4935_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342. https:\/\/doi.org\/10.1016\/S1470-2045(20)30555-6","journal-title":"Lancet Oncol"},{"issue":"25","key":"4935_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M et al (2022) PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 386(25):2363\u20132376. https:\/\/doi.org\/10.1056\/NEJMoa2201445","journal-title":"N Engl J Med"},{"issue":"34","key":"4935_CR3","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1200\/JCO.18.02309","volume":"37","author":"Y Deng","year":"2019","unstructured":"Deng Y, Chi P, Lan P, Wang L, Chen W, Cui L et al (2019) Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol 37(34):3223\u20133233. https:\/\/doi.org\/10.1200\/JCO.18.02309","journal-title":"J Clin Oncol"},{"issue":"34","key":"4935_CR4","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1200\/JCO.19.00308","volume":"37","author":"E Fokas","year":"2019","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R et al (2019) Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol 37(34):3212\u20133222. https:\/\/doi.org\/10.1200\/JCO.19.00308","journal-title":"J Clin Oncol"},{"issue":"2","key":"4935_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0000000000004499","volume":"276","author":"AC Lord","year":"2022","unstructured":"Lord AC, D\u2019Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, Rasheed S, Chandramohan A, Corr A, Chau I, Brown G (2022) MRI-diagnosed tumor deposits and emvi status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg 276(2):334\u2013344. https:\/\/doi.org\/10.1097\/SLA.0000000000004499","journal-title":"Ann Surg"},{"issue":"7","key":"4935_CR6","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1245\/s10434-023-13225-9","volume":"30","author":"HM Thompson","year":"2023","unstructured":"Thompson HM, Bates DDB, Pernicka JG, Park SJ, Nourbakhsh M, Fuqua JL 3rd, Fiasconaro M, Lavery JA, Wei IH, Pappou EP, Smith JJ, Nash GM, Weiser MR, Paty PB, Garcia-Aguilar J, Widmar M (2023) MRI assessment of extramural venous invasion before and after total neoadjuvant therapy for locally advanced rectal cancer and its association with disease-free and overall survival. Ann Surg Oncol 30(7):3957\u20133965. https:\/\/doi.org\/10.1245\/s10434-023-13225-9","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4935_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1148\/radiol.211986","volume":"303","author":"J Shin","year":"2022","unstructured":"Shin J, Seo N, Baek SE, Son NH, Lim JS, Kim NK, Koom WS, Kim S (2022) MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy. Radiology 303(2):351\u2013358. https:\/\/doi.org\/10.1148\/radiol.211986","journal-title":"Radiology"},{"issue":"3","key":"4935_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5152\/dir.2018.17286","volume":"24","author":"Y Sun","year":"2018","unstructured":"Sun Y, Li J, Shen L, Wang X, Tong T, Gu Y (2018) Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation. Diagn Interv Radiol 24(3):128\u2013134. https:\/\/doi.org\/10.5152\/dir.2018.17286","journal-title":"Diagn Interv Radiol"},{"key":"4935_CR9","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2147\/CMAR.S179151","volume":"10","author":"J Wei","year":"2018","unstructured":"Wei J, Huang R, Guo S, Zhang X, Xi S, Wang Q, Chang H, Wang X, Xiao W, Zeng Z, Gao Y (2018) ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Cancer Manag Res 10:5219\u20135225. https:\/\/doi.org\/10.2147\/CMAR.S179151","journal-title":"Cancer Manag Res"},{"issue":"6","key":"4935_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, P\u00e5hlman L, Glimelius B, van de Velde CJ (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(11)70097-3","journal-title":"Lancet Oncol"},{"key":"4935_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.07.131","volume":"104","author":"MRS Siddiqui","year":"2018","unstructured":"Siddiqui MRS, Simillis C, Bhoday J, Battersby NJ, Mok J, Rasheed S, Tekkis P, Abulafi AM, Brown G (2018) A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours. Eur J Cancer 104:47\u201361. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.131","journal-title":"Eur J Cancer"},{"issue":"1","key":"4935_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/codi.13565","volume":"19","author":"R Zinicola","year":"2017","unstructured":"Zinicola R, Pedrazzi G, Haboubi N, Nicholls RJ (2017) The degree of extramural spread of T3 rectal cancer: an appeal to the American Joint Committee on Cancer. Colorectal Dis 19(1):8\u201315. https:\/\/doi.org\/10.1111\/codi.13565","journal-title":"Colorectal Dis"},{"issue":"3","key":"4935_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jcu.23623","volume":"52","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zang Y, Zhou D, Chen Z, Xin C, Zang W, Tu X (2024) The importance of preoperative T3 stage substaging by 3D endorectal ultrasonography for the prognosis of middle and low rectal cancer. J Clin Ultrasound 52(3):249\u2013254. https:\/\/doi.org\/10.1002\/jcu.23623","journal-title":"J Clin Ultrasound"},{"key":"4935_CR14","doi-asserted-by":"publisher","unstructured":"Garc\u00eda Botello S, Mart\u00ed Fern\u00e1ndez R, Cozar Lozano C, Campos Salher S, Mart\u00edn Ar\u00e9valo J, Moro Valdezate D, Pla Mart\u00ed V, Esp\u00ed Mac\u00edas A (2022) Concordance and survival implications of preoperative subclassification of T3 rectal cancers by depth of mesorectal invasion using a 5-mm cut-off point with endorectal ultrasound and magnetic resonance imaging. Quant Imaging Med Surg 12(4):2356-2367. https:\/\/doi.org\/10.21037\/qims-21-880","DOI":"10.21037\/qims-21-880"},{"issue":"6","key":"4935_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2214\/AJR.13.11311","volume":"202","author":"SH Cho","year":"2014","unstructured":"Cho SH, Kim SH, Bae JH, Jang YJ, Kim HJ, Lee D, Park JS (2014) Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal. AJR Am J Roentgenol 202(6):1238\u201344. https:\/\/doi.org\/10.2214\/AJR.13.11311","journal-title":"AJR Am J Roentgenol"},{"key":"4935_CR16","doi-asserted-by":"publisher","unstructured":"Department of Medical Administration, National Health Comimission, Chinese Society of Oncology (2023) Chinese protocol of diagnosis and treatment of colorectal cancer of the national health commission (2023 edition). Zhonghua Wei Chang Wai Ke Za Zhi, 26(6):505-528. https:\/\/doi.org\/10.3760\/cma.j.cn441530-20230525-00182","DOI":"10.3760\/cma.j.cn441530-20230525-00182"},{"issue":"10","key":"4935_CR17","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.7150\/jca.17930.PMID:28819391;PMCID:PMC5556657","volume":"8","author":"CH Chen","year":"2017","unstructured":"Chen CH, Hsieh MC, Hsiao PK, Lin EK, Lu YJ, Wu SY (2017) A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer 8(10):1927\u20131934. https:\/\/doi.org\/10.7150\/jca.17930.PMID:28819391;PMCID:PMC5556657","journal-title":"J Cancer"},{"key":"4935_CR18","doi-asserted-by":"publisher","first-page":"678441","DOI":"10.3389\/fonc.2021.678441","volume":"11","author":"J You","year":"2021","unstructured":"You J, Yin J (2021) Performances of Whole Tumor Texture Analysis Based on MRI: Predicting Preoperative T Stage of Rectal Carcinomas. Front Oncol 11:678441. https:\/\/doi.org\/10.3389\/fonc.2021.678441","journal-title":"Front Oncol"},{"key":"4935_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-230X-10-61","volume":"10","author":"I Zlobec","year":"2010","unstructured":"Zlobec I, Minoo P, Karamitopoulou E, Peros G, Patsouris ES, Lehmann F, Lugli A (2010) Role of tumor size in the pre-operative management of rectal cancer patients. BMC Gastroenterol 10:61. https:\/\/doi.org\/10.1186\/1471-230X-10-61","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"4935_CR20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1200\/JCO.2004.08.173","volume":"22","author":"LL Gunderson","year":"2004","unstructured":"Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O\u2019Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785\u201396. https:\/\/doi.org\/10.1200\/JCO.2004.08.173","journal-title":"J Clin Oncol"},{"issue":"2","key":"4935_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2009.23.9194","volume":"28","author":"LL Gunderson","year":"2010","unstructured":"Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A (2010) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 28(2):256\u201363. https:\/\/doi.org\/10.1200\/JCO.2009.23.9194","journal-title":"J Clin Oncol"},{"issue":"12","key":"4935_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/bjc.2017.99","volume":"116","author":"MRS Siddiqui","year":"2017","unstructured":"Siddiqui MRS, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G (2017) A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer 116(12):1513\u20131519. https:\/\/doi.org\/10.1038\/bjc.2017.99","journal-title":"Br J Cancer"},{"issue":"2","key":"4935_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/SLA.0000000000004636","volume":"275","author":"F Rouleau Fournier","year":"2022","unstructured":"Rouleau Fournier F, Motamedi MAK, Brown CJ, Phang T, Raval MJ, Hague CJ, Karimuddin AA (2022) Oncologic outcomes associated with mri-detected extramural venous invasion (mremvi) in rectal cancer: a systematic review and meta-analysis. Ann Surg 275(2):303\u2013314. https:\/\/doi.org\/10.1097\/SLA.0000000000004636","journal-title":"Ann Surg"},{"issue":"6","key":"4935_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.asjsur.2021.01.011","volume":"44","author":"OS Guner","year":"2021","unstructured":"Guner OS, Tumay LV (2021) Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer. Asian J Surg 44(6):841\u2013847. https:\/\/doi.org\/10.1016\/j.asjsur.2021.01.011","journal-title":"Asian J Surg"},{"issue":"2","key":"4935_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","volume":"15","author":"JF Bosset","year":"2014","unstructured":"Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ et al (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184\u201390. https:\/\/doi.org\/10.1016\/S1470-2045(13)70599-0","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04935-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:44:40Z","timestamp":1751071480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4935"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04935-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"7 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}